Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections. - Rodríguez-Rojas, Alexandro; Maciá, María D.; Couce, Alejandro; Gómez, Cristina; Castañeda-García, Alfredo; Oliver, Antonio; Blázquez, Jesús (PLoS ONE, 2010)